Find your next paid study

Cartography BiosciencesNCT07321106

Actual pay is set by the research site.

A Phase 1a/b, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-C137, an Antibody-Drug Conjugate Targeting FGFR2b, in Patients With Advanced Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 alone…

Advanced Solid Tumor

BeOne MedicinesNCT06625593

~$150 – $4,500

Actual pay is set by the research site.

Opioid Abuse and Addiction

A Phase 1, Open-Label, Safety, Tolerability, and Pharmacokinetic Study of Nalmefene Implants in Healthy Subjects

The goal of this clinical trial is to learn how safe either one or two nalmefene implants are after remaining implanted for 4 or 12 weeks. Additionally the ph…

ReacX Pharmaceuticals, Inc.NCT07325279

~$500 – $10,500

Actual pay is set by the research site.

Locally Advanced Solid Tumor

A Phase 1 Study of IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

This is a Phase 1 multicenter, multi-regional, open-label, first-in-human study of IBI3001 in participants with unresectable, locally advanced or metastatic so…

Fortvita Biologics (USA)Inc.NCT06349408

Actual pay is set by the research site.

Advanced CancerAdvanced Solid TumorCancer+1 more

A Phase 1/2 Study of BIO-106 As Monotherapy or In Combination With Pembrolizumab in Patients With Advanced Cancers (StarBridge-1)

A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.

BiOneCure Therapeutics Inc.NCT05320588

Actual pay is set by the research site.

Observational

Efficacy of an Asian Culture-tailored Lung Health (ACT) Intervention on Lung Cancer Screening and Smoking Cessation in Asian Americans

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers …

Smoking CessationSmoking BehaviorsSmoking, Tobacco+2 more

Dana-Farber Cancer InstituteNCT06945120

~$10 – $1,125

Actual pay is set by the research site.

A First-in-Human Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of FID-022 as Monotherapy in Patients With Advanced Solid Tumors

The goal of this Phase I Clinical Trial is to evaluate the safety and tolerability of FID-022 in patients with advanced solid tumors.

Advanced Solid Tumors

Fulgent Pharma LLC.NCT06694480

Actual pay is set by the research site.

Phase 2

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

This study is a two-arm phase II randomized trial investigating patients with luminal subtype muscle-invasive bladder cancer (MIBC) receiving neoadjuvant thera…

Bladder Cancer

Rutgers, The State University of New JerseyNCT07762586

~$75 – $2,000

Actual pay is set by the research site.

A Phase 1 Study of Oral PCLX-001 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

This is a dose-finding study of oral zelenirstat (PCLX-001) in patients with R/R AML. There are two parts to the study: Dose Escalation and Dose Expansion.

Relapsed Adult AML

Pacylex PharmaceuticalsNCT06613217

Actual pay is set by the research site.

Observational

Preventing Youth Violence Through Building Equitable Communities: An Evaluation of a Systemic Intervention

Interpersonal or community violence is a long-standing health disparity that disproportionately affects African American youth, and suicide is disproportionate…

SuicideViolence in Adolescence

University of South AlabamaNCT05639426

~$10 – $750

Actual pay is set by the research site.

Observational

Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain

The goal of this clinical trial is to create a machine learning algorithm to improve active repetitive transcranial magnetic stimulation (rTMS) treatments for …

Gulf War IllnessHeadacheMuscle and Joint Pain

Veterans Medical Research FoundationNCT07325513

~$10 – $675

Actual pay is set by the research site.

MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more

A Phase I/II Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6750, a CD8 Guided IL-2 Agent Alone and in Combination With Other Anti-cancer Agents in Participants With Select Advanced or Metastatic Solid Tumors

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors